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1. Introduction
Acta Pharmaceutica Hungarica (APH) was founded 
by the Hungarian society for Pharmaceutical sci-
ences (MGYT) together with its sister journal, Gyó-
gyszerészet (Pharmacy). While the latter is a month-
ly publication, which aims to assist pharmacists in 
education, continuous professional development, 
highlighting relevant literature and to inform 
about professional affairs, both in Hungary and 
on an international scale, APH is quarterly, re-
search-oriented journal, reporting on the experi-
mental results of laboratories involved in pharma-
ceutical science [1,2]. Bibliometrics is an area of sci-
ence, which is concerned with the qualitative and 
quantitative assessment of research, that is often 
used to evaluate the impact of journals, institu-
tions, study groups or individual scientists [3,4]. 
The bibliometric analysis of a given journal may 
be important for various reasons; university li-
braries often evaluate these characteristics before 
including journals in their collection. Further-
more, authors study commonly known bibliomet-
ric parameters (e.g., number of publications per 
year, impact factor, citescore, h-index) before sub-
mitting a manuscript to a journal [5,6]. Hence, the 
present study aims to give a general bibliometric 
overview of APH in a 53-year period (1965-2018), 
since the journal was listed by international con-
tent indexing services.
2. Materials and methods
The data analyzed in this study, dating between 
1965 and 2018 was extracted from the Scopus data-
base on the 15th of October 2018. The information 
was exported in ris (research information sys-
tems, Incorporated) file format to the Harzing’s 
Publish or Perish 6.35 software for data analysis 
[7,8]. In addition, VOSviewer 1.6.9 software was 
used to generate the collaboration and word co-
occurrence networks from the recovered data [9].
3. Results
The total number of documents published in APH 
during the study period (1965-2018) was 1868, the 
number of papers published since 2001 decreased 
by 46.31-47.11% compared to the two previous peri-
ods (Table I) The most frequently published docu-
ment type indexed by scopus was „original article” 
(n=1710, 91.54%), followed by „review” (n=114, 6.10%; 
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first occurrence in 1991), „short survey” (n=24, 1.28%; 
first occurrence in 1990) and 18 „conference paper” 
(n=18, 0.96%; first occurrence in 1989). There was 
only one paper classified as an „editorial” (in 2011 
[10]) and an „erratum” (in 2003), respectively. The av-
erage amount of authors per paper increased con-
sistently throughout the years (2.36-3.47; Table I).
regarding the impact of papers in APH, articles 
published between 1965 and 2018 were cited 2555 
times overall, averaging 1.37 citations per each pa-
per, with more than 57% of overall citations on ar-
ticles published in the period between 1981-2000. 
The average ratio of self-citations was 26.76% 
(0-69.23%; highest in 2001). The papers with high 
amount of citations (defined as 15 or more cites) 
correspond to 12.13% of total citations (8.86 cita-
tions per year, 140.99 cites/author) for APH (arti-
cles listed in Table II). The journal is associated with 
two subject categories, namely Medicine (miscella-
neous) and Pharmaceutical sciences. Based on the in-
Table I General bibliometric characteristics of APH between 1965-2018
Publication years 1965-1980 1981-2000 2001-2018 Overall
Number of papers 743 (39.77%) 732 (39.19%) 393 (21.04%) 1868
Citations on the papers during  
the study period (1965-2018) 600 (23.48%) 1463 (57.26%) 492 (19.26%) 2555
Cites per year 11.32 39.54 28.94 48.21
Cites per paper 0.81 2.00 1.25 1.37
Authors per paper 2.36 3.06 3.47 2.87
h-index 8 14 10 14
Figure 1 Co-author collaboration network from documents published in APH between 1965-2018
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ternational impact of the papers published, the 
quartile ranking of APH ranged between the sec-
ond (Q2; 2003) and fourth (Q4; consistently from 
2011 onwards) quartile (Table III). international, col-
laborative research involving multiple partners 
usually enhances the impact of published articles. 
For this reason, the ratio of collaborative publica-
tions (defined as articles with authors from more 
than one country) in APH was assessed in the 
most recent period (2001-2018). Presented in Table 
iV, the highest number of articles published in col-
laboration was in 2007 and 2018, respectively 
(16.7% in both cases).
To establish the network of strong collaborators 
and the profile of APH in more depth, the authors 
and the words present in the titles and abstracts of 
the published documents were analyzed by VOs-
viewer with the aim of generating clusters and co-
occurrence networks. Together with the connect-
ing lines, the colors in Figures 1 and 3 indicate the 
relationship of the authors and keywords, while in 
Figures 2 and 4, the shade of color indicates the 
temporal nature of relationships.
Out of 2644 authors, 186 met the threshold to 
become “nodes” in the generated network, while 
159 could be included in the network (i.e., had at 
least one co-authored paper with another author 
qualifying to be a “node”) to generate clusters of 
association (Figure 1-2). Overall, 7901 keywords 
were identified by VOSviewer, from which 1164 
met the threshold to become “nodes” and 180 was 
enrolled in the generation of the co-occurrence 
network (Figure 3-4). Beginning with 1990, the 
most prevalent keywords were “high perfor-
mance liquid chromatography”, “animal tissue”, 
“human/humans”, “drug release”, “bioavailabili-
ty”, “drug solubility”, “drug manufacture”, 
“plant extract”, particle size”, “molecular struc-
ture”, “mass spectrometry” and “nuclear magnet-
ic resonance”, reflecting on the changing trends in 
pharmaceutical sciences in the period of 1980-
2000.
Figure 2 Overlay visualization of co-author collaboration based on year of publication in APH between 1965-2018
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4. Discussion
The aim of this study was to assess APH using bib-
liometric methods in the time period between 
1965-2018, in which indexing data was available 
from the scopus database. From an institutional 
perspective, most of the papers originated from the 
four universities in Hungary (Budapest, debrecen, 
Pécs and szeged) where there is a Faculty of Phar-
macy or the training of pharmacists takes place. in 
addition, the Budapest University of Technology 
(BME) and some industrial institutions (e.g., Gede-
on richter Ltd.) were also important contributors. 
citations are generally considered an important 
parameter to assess the quality of papers published 
in any given journal, however, the absolute number 
of citations is not always informative (self-citations 
or “negative citations” that call attention to flawed 
papers may distort this bibliometric indicator). The 
average ratio of self-citations for APH was 26.76%, 
which can be considered a good result, compared 
to other journals published in Hungary. Overall, 
the 20-year period between 1981-2000 was the most 
fruitful for this journal, based on the number of 
published articles and the amount of citations, 
while the following years between 2001 and 2018 
saw a decline in the number of articles by almost 
50% and the number of citations by nearly 300%, 
whereas the ratio of papers reporting on the re-
search of international collaboration was variable 
[25-27]. The reason for this decrease may be attrib-
utable to the increasing pressure to publish in in-
ternational journals with (preferably high) impact 
factors, because this has become a pre-requisite for 
the awarding of doctoral (Phd) degrees and for 
successful application for research grants.
Figure 3 Keyword co-occurrence network from documents published in APH between 1965-2018
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Table III Quartile ranking of APH between 2001-2018
Category 2001 2002 2003 2004 2005 2006 2007 2008 2009
Medicine (miscellaneous) Q3 Q3 Q2 Q3 Q3 Q3 Q3 Q3 Q4
Pharmaceutical sciences Q3 Q3 Q2 Q3 Q4 Q3 Q3 Q4 Q4
2010 2011 2012 2013 2014 2015 2016 2017 2018
Medicine (miscellaneous) Q3 Q4 Q4 Q4 Q4 Q4 Q4 Q4 Q4
Pharmaceutical sciences Q3 Q4 Q4 Q4 Q4 Q3 Q4 Q4 Q4
Table IV Articles published in international collaboration in APH between 2001-2018
2001 2002 2003 2004 2005 2006 2007 2008 2009
Precentage
0% 0% 6.1% 3.7% 4.4% 8.3% 16.7% 10.5% 5.0%
2010 2011 2012 2013 2014 2015 2016 2017 2018
0% 6.7% 0% 6.7% 5.6% 0% 15.8% 0% 16.7%
Table II Publications from APH with the most amount of citations 
Publication Year Type Citations Cites/year
Kiss, B.., Kárpáti, E.: 
 On the mechanism of action of vinpocetine [11] 1996 review 35 1.59
Fejes, s., Kéry, á., Blázovics, A., Lugasi, A., Lemberkovics, É., Petri, 
G., Szőke, É.: 
Investigation of the in vitro antioxidant effect of Petroselinum crispum 
(Mill.) Nym. ex A. W. Hill. [12]
1998 Article 29 1.45
Medhin, d.G., Hadházy, P., Bakos, P., Verzár-Petri, G.: 
Hypotensive effects of Lupinus termis and Coriandrum sativum in anaes-
thetized rats. A preliminary study [13]
1986 Article 29 0.91
Matus, Z., Molnár, P., szabó Gy.: 
Main carotenoids in pressed seed (Cucurbitae semen) of oil-pumpkin (Cu-
curbita pepo convar. pepo var. styriaca) [14]
1993 Article 26 1.04
császár, j., Morvay, j.: 
Characteristics of Schiff bases derived from salicylaldehyde and sulphon-
amides. Spectral and antibacterial studies [15] 
1983 Article 25 0.71
Budai, M., szógyi, M.: 
Liposomes as drug carrier systems. Preparation, classification and therapeu-
tical advantages of liposomes [16]
2001 Article 23 1.35
issopoulos, P.B.: 
Analytical investigations of β-lactam antibiotics in pharmaceutical prepara-
tions. IV. Sensitive colorimetric determination of five cephalosporins of the 
first generation [17]
1991 Article 23 0.85
Kéry, A., Horváth, j., Nász, i., Verzár-Petri, G., Kulcsár, G., dán, P.: 
Antiviral alkaloid in Chelidonium majus L. [18] 1987 Article 20 0.65
Lemberkovics, É.,, Kéry, Á., Marczal, G., Simándi, B., Szőke, É.: 
Phytochemical evaluation of essential oils, medicinal plants and their prepa-
rations [19]
1998 short survey 18 0.90
El-Brashy, A.M.: 
Titrimetric determination of captopril in dosage forms [20] 1995 Article 18 0.78
issopoulos, P.B.: 
 A sensitive spectrophotometric determination of acetaminophen [21] 1992 Article 17 0.65
sarg, T.M., Ateya, A.M., Farrag, N.M., Abbas, F.A.: 
Constituents and biological activity of Bidens pilosa L. grown in Egypt [22] 1991 Article 16 0.59
Kata, M., schauer, M.: 
Increasing the solubility characteristics of albendazole with dimethyl-β-
cyclodextrin [23]
1991 Article 16 0.59
szántay cs. jr., Bihari, M., Brlik, j., csehi, A., Kassai, A., Aranyi, A.: 
Structural elucidation of two novel ergot alkaloid impurities in 
α-ergokryptine and bromokryptine [24]
1994 Article 15 0.63
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5. Conclusions
This study presents a qualitative and quantitative 
bibliometric analysis of the leading trends that oc-
curred in the journal between 1965 and 2018, us-
ing the scopus database for the collection of bibli-
ographic information and specialized software for 
data analysis. To assess APH from a different per-
spective, this research also presents keyword co-
occurrence and collaboration networks of the 
journal. Acta Pharmaceutica Hungarica manages to 
reach a very wide audience of the Hungarian sci-
entific community of researchers interested in its 
content. Additionally, an evolution on the research 
topics covered by the journal could be observed, 
providing a contemporary overview of the phar-
maceutical sciences. The submission of additional 
articles to the journal is highly encouraged to wid-
en the reach of this journal towards international 
audiences.
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